John White is retired from the biotechnology/medical device research industry after 33 years of service, with stints in bedside patient monitoring, cardiac care, ophthalmology and finished in flow immunocytometry for development of monoclonal antibodies used in many precision targeted therapies for immune system diseases and all forms of cancer. He is a patient ambassador/advocate for the Cancer Research Institute for the advancement of immunotherapeutics and shares his unique cancer journey with other patients, researchers and doctors across the country. John enjoys classic cars (including his own 1923 Ford T-Bucket Roadster), gardening, and is an avid golfer. He looks forward to sharing his story as an inspiration to others. John is considered an exceptional responder to immune checkpoint inhibitors PD-1 immunotherapy for small cell neuroendocrine differentiation metastatic prostate cancer Stage 4, with currently 8 years of long-term durable clinical remission and no evidence of disease (NED) … one of the many medical miracles.